New research has found "no evidence" that commonly prescribed hormone therapies for menopausal women either increase or decrease the risk of dementia. While experts stress that more studies are needed ...

Women who use hormone replacement therapy (HRT) for at least a decade before their final period may see a reduced risk of breast cancer, heart attacks, or strokes, according to a new analysis.

While hormone replacement therapy (HRT) is not broadly linked to young-onset breast cancer, using certain types before menopause could increase the risk of it developing in young women, a new study ...

For confidential advice, call Alzheimer's Society's Dementia Support Line on 0333 150 3456 Alzheimer's Society's symptoms checker can help spot the signs of dementia Taking hormone replacement therapy ...

HRT does not increase breast cancer risk in BRCA1/BRCA2 variant carriers, with lower incidence in users versus non-users. Estrogen-alone therapy is linked to reduced mortality, while estrogen plus ...

As awareness of hormone replacement therapy grows, so does enthusiasm. But the rapidly evolving conversation around HRT may be oversimplifying a highly individualized medical decision. This voice ...

Researchers conducted a nested case-control study to examine if the use of exogenous estrogen‑only, progestogen‑only, or combined estrogen-progestogen HRT was associated with the development of ...

The Food and Drug Administration will remove black box warnings from hormone replacement therapy (HRT) products, which are often used to treat menopause, the Department of Health and Human Services ...

No, hormone therapy does not directly cause cancer. However, depending on your personal level of risk, hormone therapy can increase the risk of developing certain kinds of cancer, such as breast ...

Share on Pinterest The FDA has initiated changes to the black box warnings on HRT products. Lupe Rodriguez/Stocksy The Food and Drug Administration (FDA) has approved drug labeling changes to black ...